- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
- Paralegals
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 22, 2023Robins Kaplan Attorneys Named 2023 New York Super Lawyers and Rising Stars
-
September 12, 2023Annie Huang Receives Asian Leadership Award from Profiles in Diversity Journal
-
September 12, 2023Robins Kaplan Partners Named to 2024 Lawdragon 500 Leading Litigators in America Guide
-
September 26-28, 20236th Annual LF Dealmakers Forum
-
September 28-29, 20232023 Midwest IP Institute
-
October 4, 2023Lying, Cheating, and Stealing Seminar 2023
-
August 21, 2023Colorado Expands Antitrust Protection
-
July 18, 2023Copyright: Rights Even Heroes Can't Protect
-
August 2023Minnesota Bans Non-Competes Formed on or After July 1, 2023: Assessing Remaining Strategies to Protect Confidential Information and Trade Secrets
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
New Drug Applications and 505(b)(2) Applications
Second Quarter

This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA.
Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
---|---|---|---|---|
4/1/2022 | Permitil | Fluphenazine HCl | Schering | TWi Pharms |
4/4/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Sandoz |
4/5/2022 | Paraflex | Chlorzoxazone | Johnson & Johnson | Rising |
4/6/2022 | Frova | Frovatriptan Succinate | Endo | Renata |
4/6/2022 | BiDiL | Isosorbide Dinitrate / Hydralazine HCl | Azurity | Riconpharma |
4/7/2022 | Noxafil | Posaconazole | Merck | Dr Reddy's |
4/7/2022 | Ganirelix | Ganirelix Acetate | Organon | Amphastar Pharms |
4/7/2022 | Bystolic | Nebivolol HCl | AbbVie | Prinston |
4/7/2022 | Allzital/Butapap | Butalbital / Acetaminophen | Larken / Mikart | Senores Pharms |
4/7/2022 | Vimpat | Lacosamide | UCB | Indoco |
4/8/2022 | Emla | Lidocaine / Prilocaine | Teva | Aleor Dermaceuticals |
4/8/2022 | Elcys | Cysteine HCl | Exela | Dr Reddy's |
4/11/2022 | Lexiscan | Regadenoson | Astellas | Apotex |
4/11/2022 | Lexiscan | Regadenoson | Astellas | Hong Kong |
4/11/2022 | Lexiscan | Regadenoson | Astellas | Dr Reddy's |
4/11/2022 | Lexiscan | Regadenoson | Astellas | Accord Healthcare |
4/11/2022 | Dotarem | Gadoterate Meglumine | Guerbet | Hengrui Pharma |
4/11/2022 | Sutent | Sunitinib Malate | Pfizer | Dr Reddy's |
4/12/2022 | Alphatrex | Betamethasone Dipropionate | Savage | Padagis |
4/13/2022 | Intelence | Etravirine | Johnson & Johnson | Carnegie |
4/14/2022 | Tikosyn | Dofetilide | Pfizer | Vgyaan |
4/14/2022 | Prolixin | Fluphenazine HCl | BMS | Taro Pharm |
4/14/2022 | Akovaz | Ephedrine Sulfate | Exela | Mankind Pharma |
4/15/2022 | Tikosyn | Dofetilide | Pfizer | Teva |
4/15/2022 | Dacogen | Decitabine | Otsuka | Jiangsu Hansoh Pharm |
4/15/2022 | Vibisone | Cyanocobalamin | Fresenius Kabi | Zydus |
4/15/2022 | Vibisone | Cyanocobalamin | Fresenius Kabi | Welding |
4/15/2022 | Carafate | Sucralfate | Allergan | Amneal Pharms |
4/15/2022 | Dotarem | Gadoterate Meglumine | Guerbet | Hengrui Pharma |
4/19/2022 | Mestinon | Pyridostigmine Bromide | Bausch | Milla Pharms |
4/19/2022 | Doxepin HCl | Doxepin HCl | Pfizer | Edenbridge Pharms |
4/20/2022 | Combigan | Brimonidine Tartrate / Timolol Maleate | AbbVie | Apotex |
4/20/2022 | Thiamine HCl | Thiamine HCl | Fresenius Kabi | Eugia Pharma |
4/21/2022 | Akovaz | Ephedrine Sulfate | Exela | Aggrega |
4/21/2022 | Olux | Clobetasol Propionate | Mylan | Aleor Dermaceuticals |
4/22/2022 | Xtandi | Enzalutamide | Astellas | Apotex |
4/22/2022 | Vitamin K1 | Phytonadione | Hospira | Cipla |
4/26/2022 | Seroquel XR | Quetiapine Fumarate | AstraZeneca | Prinston |
4/27/2022 | Ranexa | Ranolazine | Gilead | I3 Pharms |
4/27/2022 | Targretin | Bexarotene | Bausch | Amneal |
4/28/2022 | Esbriet | Pirfenidone | Genentech | Sandoz |
4/28/2022 | Taytulla | Norethindrone Acetate / Ethinyl Estradiol / Ferrous Fumarate | Apil | Mayne Pharma |
4/29/2022 | Intal | Cromolyn Sodium | King | Micro Labs |
4/29/2022 | Imdur | Isosorbide Mononitrate | Schering | Shandong |
5/2/2022 | Velcade | Bortezomib | Takeda | Apotex |
5/2/2022 | Velcade | Bortezomib | Takeda | Teva |
5/2/2022 | Velcade | Bortezomib | Takeda | Sagent / Pharmascience |
5/2/2022 | Velcade | Bortezomib | Takeda | Fresenius Kabi |
5/2/2022 | Velcade | Bortezomib | Takeda | Zydus |
5/2/2022 | Velcade | Bortezomib | Takeda | Ingenus / Qilu Pharm Hainan |
5/2/2022 | Velcade | Bortezomib | Takeda | Eugia Pharma |
5/2/2022 | Velcade | Bortezomib | Takeda | Baxter Healthcare |
5/2/2022 | Tamiflu | Oseltamivir Phosphate | Roche | MSN |
5/3/2022 | Lyrica | Pregabalin | Pfizer | Lupin |
5/3/2022 | Zyflo CR | Zileuton | Chiesi | Teva |
5/3/2022 | Vimpat | Lacosamide | UCB | Fresenius Kabi |
5/3/2022 | Abreva | Docosanol | Glaxo | Aleor Dermaceuticals |
5/3/2022 | Zinc Sulfate | Zinc Sulfate | American Regent | Gland Pharma |
5/4/2022 | Pomalyst | Pomalidomide | Celgene | Teva |
5/4/2022 | Flomax | Tamsulosin HCl | Sanofi | Acme Labs |
5/5/2022 | Fanapt | Iloperidone | Vanda Pharms | Lupin |
5/5/2022 | Ranexa | Ranolazine | Gilead | Hetero Labs |
5/5/2022 | Northera | Droxidopa | Lundbeck | Celltrion |
5/5/2022 | Xylocaine | Lidocaine HCl | Fresenius Kabi | Sintetica |
5/5/2022 | Tiazac | Diltiazem HCl | Bausch | Mayne Pharma |
5/6/2022 | Pennsaid | Diclofenac Sodium | Horizon | Apotex |
5/6/2022 | Apriso | Mesalamine | Valeant | Teva |
5/9/2022 | Vfend | Voriconazole | PF Prism | Meitheal |
5/10/2022 | Norvir | Ritonavir | AbbVie | Cipla |
5/10/2022 | Synthroid | Levothyroxine Sodium | AbbVie | Teva |
5/10/2022 | Daliresp | Roflumilast | AstraZeneca | Prinston |
5/10/2022 | Noxafil | Posaconazole | Merck Sharp Dohme | Specgx |
5/10/2022 | Brovana | Arformoterol Tartrate | Sunovion | Alembic Pharms |
5/10/2022 | Sabril | Vigabatrin | Lundbeck | Aurobindo |
5/11/2022 | Requip XL | Ropinirole HCl | GlaxoSmithKline | Prinston |
5/11/2022 | Pentasa | Mesalamine | Takeda | Sun Pharm |
5/11/2022 | Cataflam | Diclofenac Potassium | Amici | Umedica Labs |
5/13/2022 | Nicorette | Nicotine Polacrilex | GlaxoSmithKline | Aurobindo |
5/13/2022 | Kuvan | Sapropterin Dihydrochloride | Biomarin | Dr Reddy's |
5/16/2022 | Bijuva | Estradiol / Progesterone | TherapeuticsMD | Amneal |
5/17/2022 | Butrans | Buprenorphine | Purdue | Alvogen |
5/18/2022 | Protonix IV | Pantoprazole Sodium | Wyeth | Gland Pharma |
5/18/2022 | Trilafon | Perphenazine | Schering | Appco |
5/18/2022 | Vantin | Cefpodoxime Proxetil | Pharmacia / Upjohn | Alkem Labs |
5/18/2022 | Esbriet | Pirfenidone | Genentech | Micro Labs |
5/18/2022 | Protonix IV | Pantoprazole Sodium | Wyeth | Aspiro |
5/18/2022 | Protonix IV | Pantoprazole Sodium | Wyeth | Be Pharms |
5/19/2022 | Letairis | Ambrisentan | Gilead | Apotex |
5/19/2022 | Visapaque | Iodixanol | GE Healthcare | Hengrui Pharma |
5/19/2022 | Vimpat | Lacosamide | UCB | Alkem Labs |
5/19/2022 | Protonix IV | Pantoprazole Sodium | Wyeth | Knack |
5/20/2022 | Esbriet | Pirfenidone | Genentech | Alembic Pharms |
5/20/2022 | Aromasin | Exemestane | Pfizer | Eugia Pharma |
5/23/2022 | Lexiscan | Regadenoson | Astellas | IMS |
5/24/2022 | Esbriet | Pirfenidone | Genentech | MSN |
5/24/2022 | Nimbex | Cisatracurium Besylate | AbbVie | Piramal |
5/24/2022 | Prilosec OTC | Omeprazole Magnesium | AstraZeneca | Perrigo |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Fresenius Kabi |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Hospira |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Dr Reddy's |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Accord Healthcare |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Apotex |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Qilu Pharm Hainan |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Nang Kuang Pharm |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Jiangsu Hansoh Pharm |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Apotex |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Biocon Pharma |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Waverley Pharma |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Zydus |
5/25/2022 | Alimta | Pemetrexed Disodium | Eli Lilly | Eugia Pharma |
5/25/2022 | Noxafil | Posaconazole | Merck | Par |
5/26/2022 | Orfadin | Nitisinone | Swedish Orphan | Medunik |
5/26/2022 | Zemuron | Rocuronium Bromide | Organon | Prinston |
5/26/2022 | Brovana | Arformoterol Tartrate | Sunovion | Sun Pharm |
5/26/2022 | Atropine Sulfate | Atropine Sulfate | Hospira | American Regent |
5/26/2022 | Bumex | Bumetanide | Validus | Gland Pharma |
5/27/2022 | Symmetrel | Amantadine HCl | Endo | Edenbridge Pharms |
5/27/2022 | Keppra | Levetiracetam | UCB | Sciegen Pharms |
5/27/2022 | Children's Motrin | Ibuprofen | Johnson & Johnson | Strides Pharma |
5/27/2022 | Minocycline HCl | Minocycline HCl | Triax | Beximco Pharms |
5/27/2022 | Keppra | Levetiracetam | UCB | Alkem Labs |
5/31/2022 | Vimpat | Lacosamide | UCB | Hetero Labs |
5/31/2022 | Epiduo Forte | Adapalene / Benzoyl Peroxide | Galderma | Padagis |
5/31/2022 | Concerta | Methylphenidate HCl | Johnson & Johnson | Rhodes Pharms |
5/31/2022 | Florinef | Fludrocortisone Acetate | Casper | Novitium Pharma |
5/31/2022 | Allegra-D | Fexofenadine HCl / Pseudoephedrine HCl | Sanofi | Dr Reddy's |
5/31/2022 | Advil PM | Ibuprofen / Diphenhydramine Citrate | GlaxoSmithKline | Aurobindo |
6/1/2022 | Aleve-D | Naproxen Sodium / Pseudoephedrine HCl | Bayer | Aurobindo |
6/2/2022 | Suboxone | Buprenorphine HCl / Naloxone HCl | Indivior | Aveva |
6/2/2022 | Thiola | Tiopronin | Mission | Par |
6/3/2022 | Epiduo Forte | Adapalene / Benzoyl Peroxide | Galderma | Zydus |
6/3/2022 | Pepcid | Famotidine | Johnson & Johnson | Zydus |
6/6/2022 | Lupron | Leuprolide Acetate | AbbVie | Eugia Pharma |
6/6/2022 | Potassium Chloride | Potassium Chloride | Genus Life Sciences | Wes Pharma |
6/6/2022 | Ganirelix | Ganirelix Acetate | Merck | Hong Kong |
6/6/2022 | Elavil | Amitriptyline HCl | AstraZeneca | Centaur Pharms |
6/7/2022 | Naprosyn | Naproxen | Atnahs Pharma | Hetero Labs |
6/7/2022 | Nexavar | Sorafenib Tosylate | Bayer | Dr Reddy's |
6/8/2022 | Kabilyte | Multiple Electrolytes Injection Type 1 USP Ph 7.4 | Baxter | Fresenius Kabi |
6/8/2022 | Tenex | Guanfacine HCl | Promius | TWi Pharms |
6/9/2022 | Glumetza | Metformin HCl | Santarus | Prinston Inc |
6/9/2022 | Narcan | Naloxone HCl | Adapt | Mylan |
6/9/2022 | Infants Advil Concentrated Drops | Ibuprofen | Glaxo | Strides Pharma |
6/9/2022 | Briviact | Brivaracetam | UCB | Sunshine |
6/9/2022 | Xylocaine | Lidocaine HCl | Fresenius Kabi | Afaxys |
6/10/2022 | Narcan | Naloxone HCl | Adapt | Hikma |
6/13/2022 | Esbriet | Pirfenidone | Genentech | Sandoz |
6/13/2022 | Procomp | Prochlorperazine Maleate | Jubilant Cadista | Biophore / Zenara |
6/14/2022 | Lovenox | Enoxaparin Sodium | Sanofi | Nanjing King-Friend |
6/14/2022 | Tranxene | Clorazepate Dipotassium | Recordati | Corepharma |
6/15/2022 | Isoptin | Verapamil HCl | Mt Adams | Mankind Pharma |
6/15/2022 | Vesicare | Solifenacin Succinate | Astellas | Annora Pharma |
6/16/2022 | Seroquel | Quetiapine Fumarate | AstraZeneca | Hetero Labs |
6/16/2022 | Nasalide | Flunisolide | Ivax | Riconpharma |
6/16/2022 | Tranxene | Clorazepate Dipotassium | Recordati | Novitium Pharma |
6/21/2022 | Bicnu | Carmustine | Avet Lifesciences | Ingenus Pharms |
6/21/2022 | Narcan | Naloxone HCl | Emergent | Padagis |
6/21/2022 | Gleevec | Imatinib Mesylate | Novartis | Qilu Pharm Hainan |
6/22/2022 | Epiduo Forte | Adapalene / Benzoyl Peroxide | Galderma | Actavis |
6/22/2022 | Sabril | Vigabatrin | Lundbeck | Amneal |
6/22/2022 | Carbaglu | Carglumic Acid | Recordati | Navinta |
6/22/2022 | Tarceva | Erlotinib HCl | Roche | Eugia Pharma |
6/23/2022 | Jevtana Kit | Cabazitaxel | Sanofi | Breckenridge |
6/23/2022 | Syprine | Trientine HCl | Bausch | Hetero Lab |
6/24/2022 | Amoxil | Amoxicillin | US Antibiotics | Micro Labs |
6/24/2022 | Yonsa | Abiraterone Acetate | Sunovion | Teva |
6/24/2022 | Timoptic-XE | Timolol Maleate | Bausch | Gland Pharma |
6/24/2022 | Sabril | Vigabatrin | Lundbeck | Elite Labs |
6/24/2022 | Sinequan | Doxepin HCl | Pfizer | MSN |
6/24/2022 | Nexium 24 Hr | Esomeprazole Magnesium | AstraZeneca | Graviti Pharms |
6/27/2022 | Amitiza | Lubiprostone | Sucampo | Par / Anchen |
6/27/2022 | Parnate | Tranylcypromine Sulfate | Concordia | CrossMedika |
6/27/2022 | Gastrografin | Diatrizoate Meglumine / Diatrizoate Sodium | Bracco | Guardian Drug |
6/28/2022 | Nimbex | Cisatracurium Besylate | AbbVie | Hikma |
6/28/2022 | Mysoline | Primidone | Bausch | Rubicon |
6/29/2022 | Invega | Paliperidone | Johnson & Johnson | Lupin |
6/29/2022 | Vimpat | Lacosamide | UCB | Zydus |
6/29/2022 | Epaned O.S. | Enalapril Maleate | Azurity | Amneal |
6/29/2022 | PlasmaLyte | Multiple Electrolytes Injection Type 1 USP Ph 5.5 | Baxter | Fresenius Kabi |
GENERICally Speaking Hatch Waxman Bulletin
Related Professionals
Christopher A. Pinahs
Partner
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
Second Quarter
Generically Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Second Quarter
ANDA Approvals
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
ANDA Litigation Settlements
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
Generic Launches
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
New ANDA Cases
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.